Healthy lifestyle changes, such as eating healthy food, and being active, can help – and now, there are new digital support options like Omada.
A prediabetes diagnosis offers a valuable opportunity to take action to protect your health, according to clinicians.
“Type 2 diabetes is preventable,” said Dr. Carolyn Jasik, chief medical officer of Omada Health, a digital tool that helps individuals make behavioral changes that improve their health. “Patients who embrace lifestyle changes have a good shot at never developing diabetes.”
Read More: https://coverage.bluecrossma.com/article/taking-action-prediabetes
Via: Coverage Wei-Li Shao, president of Omada Health, provides insight on financial trends in digital health investment, and what the virtual-first care approach means for the future of health care. Via: Health Evolution When Sean Duffy co-founded Omada Health in 2011, the pursuit was to reinvent how people manage chronic disease. Via: Healio The FDA approved an expanded indication for a transcarotid stent system to include patients at standard risk for adverse events from carotid endarterectomy, according to a press release from Silk Road Medical. Silk Road Medical’s Enroute TCAR System Approved for Expanded Indication of Standard-Risk Patients5/2/2022
Via: Endovascular Today May 2, 2022—Silk Road Medical, Inc. announced that the FDA approved expanded indications for the company’s Enroute stent for transcarotid artery revascularization (TCAR) to include patients at standard risk for adverse events from carotid endarterectomy (CEA). Previously, the stent was approved for use only in patients with anatomic or physiologic criteria that put them at high risk of complications from more invasive surgical procedures. Via: GlobalNewswire SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in acute ischemic stroke intervention, today announced the first patient enrollment in its SUMMIT MAX clinical trial. SUMMIT MAX is a randomized, controlled, multi-center trial to evaluate the performance of its next generation Monopoint Reperfusion System versus currently available aspiration catheter technology. The first patient was enrolled at Auckland City Hospital in New Zealand, followed shortly by a patient at West Virginia University Medicine in the United States. WVU Rockefeller Neuroscience Institute first in U.S. to enroll patient in stroke clinical trial2/8/2022
Via: WVUMedicine MORGANTOWN, W.Va. – The WVU Rockefeller Neuroscience Institute was first institution in the United States to enroll a patient in the Route 92 Medical, Inc. SUMMIT MAX clinical trial. SUMMIT MAX is a randomized, controlled, multicenter trial to evaluate the performance of its next generation Monopoint™ Reperfusion System versus currently available aspiration catheter technology. Omada Health – How Companies Can Help Employees Manage Chronic Health Conditions with Sean Duffy1/21/2022
Via: RecruitingDaily On today’s episode of the RecruitingDaily Podcast, William Tincup speaks with Sean Duffy, co-founder and CEO at Omada Health about how companies can help their employees manage chronic health conditions. Via: GlobalNewswire Rosemont, Ill., Dec. 27, 2021 (GLOBE NEWSWIRE) -- A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted life years (QALY). Via: VascularNews A systematic review and meta-analysis has found that transcarotid artery revascularisation (TCAR) is associated with “promising early and late outcomes” in patients with internal carotid artery stenosis, although symptomatic patients still carry a higher risk of early cerebrovascular events. This is the conclusion of George C Galyfos (Hippocration Hospital, Athens, Greece) and colleagues, whose work was published as an Editor’s Choice paper in the European Journal of Vascular and Endovascular Surgery (EJVES). |
Archives
October 2023
|